These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9402354)

  • 1. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis.
    March F; Garriga X; Rodríguez P; Moreno C; Garrigó M; Coll P; Prats G
    Clin Infect Dis; 1997 Nov; 25(5):1044-7. PubMed ID: 9402354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team.
    Perlman DC; El Sadr WM; Heifets LB; Nelson ET; Matts JP; Chirgwin K; Salomon N; Telzak EE; Klein O; Kreiswirth BN; Musser JM; Hafner R
    AIDS; 1997 Oct; 11(12):1473-8. PubMed ID: 9342069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
    Nolan CM; Williams DL; Cave MD; Eisenach KD; el-Hajj H; Hooton TM; Thompson RL; Goldberg SV
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1067-71. PubMed ID: 7663785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain.
    Rullán JV; Herrera D; Cano R; Moreno V; Godoy P; Peiró EF; Castell J; Ibañez C; Ortega A; Agudo LS; Pozo F
    Emerg Infect Dis; 1996; 2(2):125-9. PubMed ID: 8903213
    [No Abstract]   [Full Text] [Related]  

  • 7. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS.
    Lutfey M; Della-Latta P; Kapur V; Palumbo LA; Gurner D; Stotzky G; Brudney K; Dobkin J; Moss A; Musser JM; Kreiswirth BN
    Am J Respir Crit Care Med; 1996 Feb; 153(2):837-40. PubMed ID: 8564140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characteristics and Drug Susceptibility of Mycobacterium tuberculosis Isolates from Patients Co-infected with Human Immunodeficiency Virus in Beijing, China.
    Liu J; Wang HZ; Lian LL; Yu YH; Zhao XQ; Guo CP; Liu HC; Liu SM; Zhao H; Zeng ZY; Zhao XY; Wan KL
    Biomed Environ Sci; 2015 Mar; 28(3):222-6. PubMed ID: 25800448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.
    Datta G; Nieto LM; Davidson RM; Mehaffy C; Pederson C; Dobos KM; Strong M
    Tuberculosis (Edinb); 2016 May; 98():50-5. PubMed ID: 27156618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis and drug resistance among patients seen at an AIDS Reference Center in São Paulo, Brazil.
    Pinto WP; Hadad DJ; Silva Telles MA; Ueki SY; Palaci M; Basile MA
    Int J Infect Dis; 2001; 5(2):93-100. PubMed ID: 11468105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
    Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
    BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.
    Coll P; Aragón LM; Alcaide F; Espasa M; Garrigó M; González J; Manterola JM; Orús P; Salvadó M
    Microb Drug Resist; 2005; 11(2):107-14. PubMed ID: 15910223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G; Tezcan S; Serin MS; Emekdas G
    Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.